Leanne Hodson1, Fredrik Karpe. 1. Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK. leanne.hodson@ocdem.ox.ac.uk
Abstract
PURPOSE OF REVIEW: The fatty acid, palmitoleate (16:1 n - 7), has received a lot of attention in recent years for being 'lipokine' and for the first time, we review the evidence to determine if there is something special about palmitoleate in humans. RECENT FINDINGS: Despite dietary intakes being low (<4% of total energy) palmitoleate is the second most abundant monounsaturated fatty acid in most, but not all, blood lipid pools and notably more abundant in adipose tissue. Thus, compared with other fatty acids, the palmitoleate content of lipid pools must be influenced by endogenous synthesis, which appears to be tissue and depot specific. We present a summary of dietary intervention studies of food components enriched in palmitoleate but this gives inconclusive results in regards to an impact on human metabolic regulation. SUMMARY: To date, there is no strong evidence from human studies suggesting that palmitoleate has 'lipokine' effects. However, unlike other fatty acids, there is a clear tendency towards compartmentalization and tissue-specific formation of palmitoleate, which is intriguing and requires further investigation.
PURPOSE OF REVIEW: The fatty acid, palmitoleate (16:1 n - 7), has received a lot of attention in recent years for being 'lipokine' and for the first time, we review the evidence to determine if there is something special about palmitoleate in humans. RECENT FINDINGS: Despite dietary intakes being low (<4% of total energy) palmitoleate is the second most abundant monounsaturated fatty acid in most, but not all, blood lipid pools and notably more abundant in adipose tissue. Thus, compared with other fatty acids, the palmitoleate content of lipid pools must be influenced by endogenous synthesis, which appears to be tissue and depot specific. We present a summary of dietary intervention studies of food components enriched in palmitoleate but this gives inconclusive results in regards to an impact on human metabolic regulation. SUMMARY: To date, there is no strong evidence from human studies suggesting that palmitoleate has 'lipokine' effects. However, unlike other fatty acids, there is a clear tendency towards compartmentalization and tissue-specific formation of palmitoleate, which is intriguing and requires further investigation.
Authors: Elizabeth Brett; Natalie Chung; William Tripp Leavitt; Arash Momeni; Michael T Longaker; Derrick C Wan Journal: Tissue Eng Part B Rev Date: 2017-04-27 Impact factor: 6.389
Authors: Henry C Liu; Neema Jamshidi; Yuchen Chen; Satish A Eraly; Sai Yee Cho; Vibha Bhatnagar; Wei Wu; Kevin T Bush; Ruben Abagyan; Bernhard O Palsson; Sanjay K Nigam Journal: J Biol Chem Date: 2016-07-20 Impact factor: 5.157
Authors: Maude Perreault; Kaitlin Roke; Alaa Badawi; Daiva E Nielsen; Salma A Abdelmagid; Ahmed El-Sohemy; David W L Ma; David M Mutch Journal: Lipids Date: 2013-12-15 Impact factor: 1.880
Authors: Joseph J Lee; Jennifer E Lambert; Yelena Hovhannisyan; Maria A Ramos-Roman; Justin R Trombold; David A Wagner; Elizabeth J Parks Journal: Am J Clin Nutr Date: 2014-11-19 Impact factor: 7.045
Authors: Hui Gyu Park; Kumar S D Kothapalli; Woo Jung Park; Christian DeAllie; Lei Liu; Allison Liang; Peter Lawrence; J Thomas Brenna Journal: Biochim Biophys Acta Date: 2015-11-17
Authors: Alma M Astudillo; Clara Meana; Carlos Guijas; Laura Pereira; Patricia Lebrero; María A Balboa; Jesús Balsinde Journal: J Lipid Res Date: 2017-11-21 Impact factor: 5.922
Authors: Jorge E Chavarro; Stacey A Kenfield; Meir J Stampfer; Massimo Loda; Hannia Campos; Howard D Sesso; Jing Ma Journal: Am J Epidemiol Date: 2013-08-28 Impact factor: 4.897